[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Chan et al., 1971 - Google Patents

Regulation of the immune response: V. An analysis of the function of the Fc portion of antibody in suppression of an immune response with respect to interaction with …

Chan et al., 1971

View PDF
Document ID
8570164359762236405
Author
Chan P
Sinclair N
Publication year
Publication venue
Immunology

External Links

Snippet

Pepsin digested, F (ab') 2 antibody has less ability to inhibit an antibody response than has intact IgG antibody, when the antibodies were given one day after antigen. F (ab') 2 antibody has to be given with antigen to attain maximal suppression, while IgG antibody …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin

Similar Documents

Publication Publication Date Title
Chan et al. Regulation of the immune response: V. An analysis of the function of the Fc portion of antibody in suppression of an immune response with respect to interaction with components of the lymphoid system
Sinclair REGULATION OF THE IMMUNE RESPONSE: I. Reduction in Ability of Specific Antibody to Inhibit Long-Lasting IgG Immunological Priming after Removal of the Fc Fragment
Basten et al. A receptor for antibody on B lymphocytes: I. Method of detection and functional significance
Manning et al. Immunosuppression of mice injected with heterologous anti-immunoglobulin heavy chain antisera
Notkins et al. Elevated γ-globulin and increased antibody production in mice infected with lactic dehydrogenase virus
MONACO et al. Some effects of purified heterologous antihuman lymphocyte serum in man
Wortis et al. Antibody production studied by means of the localized haemolysis in gel LHG assay: III. Mouse cells producing five different classes of antibody
Chan et al. Regulation of the immune response: VI. Inability of F (ab′) 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression
Unanue Thymus dependency of the immune response to hemocyanin: an evaluation of the role of macrophages in thymectomized mice
Veit et al. Immune response suppression by an inhibitor in normal and immune mouse serum
Takahashi et al. SURFACE ANTIGENS OF IMMUNOCOMPETENT CELLS: I. Effect of ϑ and PC. 1 Alloantisera on the Ability of Spleen Cells to Transfer Immune Responses
EP0240344B1 (en) Monoclonal antibodies and their use
EP0744957A1 (en) Composition and method for preventing and treating inflammation with immunoglobulin a
Riethmüller et al. In vivo and in vitro properties of intact and pepsin-digested heterologous anti-mouse thymus antibodies
Leslie et al. Modulation of immunoglobulin ontogeny in the chicken: effect of purified antibody specific for µ chain on IgM, IgY, and IgA production
Peter et al. Cell-mediated cytotoxicity during rejection and enhancement of allogeneic skin grafts in rats
Holm et al. Cytotoxicity of lymphocytes and its suppression
Heyman et al. Specific IgM enhances and IgG inhibits the induction of immunological memory in mice
Jose et al. Serum inhibitors of cellular immunity in human neuroblastoma. IgG subclass of blocking activity
Salomon et al. The immune response in NZB× NZW F1 hybrid mice
Hanna et al. Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells
JPH02111727A (en) Use of interleukin for immunological system time of reduction in immunoreaction
Makino et al. Nephritogenicity of proteoglycans. II. A model of immune complex nephritis
Ruben et al. The cellular basis of cross-tolerance
Joshua et al. Immune suppression in BALB/c mice bearing the plasmacytoma TEPC‐183: Evidence for normal lymphocyte but defective macrophage function